Makale detayı · 2016
Bioactivities of ethanolic extract and its fractions of Cistus laurifolius L Cistaceae and Salvia wiedemannii Boiss Lamiaceae species
Dergi
Pharmacognosy MagazineISSN 0973-1296
ISSN kaydı başka bir dergiye işaret ediyor; ad YÖKSİS kaydından.
- Yıl
- 2016
- Tür
- article
Veri kaynağı ayrımı
- YÖKSİS YÖKSİS makale kaydı
- YÖKSİS dergi adı Pharmacognosy Magazine
- Katalog eşleşmesi (ISSN) Pharmacognosy Magazine (discontinued)
- OpenAlex OpenAlex zenginleştirmesi (özet, atıf, konular)
Özet
OpenAlex · İngilizce
BACKGROUND: Cistus laurifolius L. (Cistaceae) and Salvia wiedemannii Boiss. (Lamiaceae) have been used for treatment of some illnesses in Turkish folk medicine. In the present study, the ethanolic extract and its fractions obtained using re-extraction by hexane (Hx), chloroform (CHCl3), butanol, and remaining-water (r-H2O) of C. laurifolius were screened for their in vitro bioactivities. MATERIALS AND METHODS: Activities were determined against both standard and the isolated strains of Escherichia coli, Pseudomonas aeruginosa, Proteus mirabilis, Klebsiella pneumoniae, Acinetobacter baumannii, Staphylococcus aureus, Enterococcus faecalis, as well as yeasts such as Candida albicans and Candida parapsilosis by microdilution method. Also, antiviral activity of C. laurifolius and S. wiedemannii extracts were tested on herpes simplex virus-1 (HSV-1) and parainfluenza-3 (PI-3) using Madin-Darby bovine kidney and vero cell lines. RESULTS: Tested extracts of C. laurifolius (minimum inhibitory concentration 32 μg/mL) exerted a strong antimicrobial activity against Gram-negative bacteria of E. coli, P. mirabilis, K. pneumoniae, and A. baumannii. CONCLUSION: The Hx extract of C. laurifolius (cytopathogenic effect of 32-8 μg/mL) had antiviral activity on PI-3. Also, the r-H2O, CHCl3, and ethanol extracts (16-<0.25 μg/mL) of S. wiedemannii had significant antiviral activity on HSV-1, same as control. SUMMARY: The objective of this study was to evaluate the bioactivity of plant extracts used in folk medicineEthanolic extract and its fractions obtained using re-extraction by hexane (Hx), chloroform (CHCl3), butanol, and remaining-water (r-H2O) of Cistus laurifolius L. (Cistaceae) and Salvia wiedemannii Boiss. (Lamiaceae) were screened against both standard and the isolated strains of E. coli, P. aeruginosa, P. mirabilis, K. pneumoniae, A. baumannii, S. aureus, E. faecalis, C. albicans and C. parapsilosis by microdilution methodAntiviral activity were tested on HSV-1 and PI-3 using MDBK and Vero cell linesExtracts of C. laurifolius exerted a strong antimicrobial activity against E. coli, P. mirabilis, K. pneumoniae, and A. baumannii(MIC; 32 μg/mL)The Hx extract of C. laurifolius had antiviral activity on PI-3 (CPE; 32-8 μg/mL). Also, the r-H2O, CHCl3, and ethanol extracts (16-<0.25 μg/mL) of S. wiedemannii had significant antiviral activity.
Konular
Atıflar
OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.
18 atıf
OpenAlex cited_by_count (önbellek / veritabanı)
Yerel katalogda bu makaleye atıf yapan 13 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).
- Antibacterial, antifungal and antiviral bioactivities of selected Helichrysum species 2018
- Koronavirüs Pandemisi ve Türkiye’nin Bazı Şifalı Bitkileri 2020
- Phytochemical analysis, antioxidant, and enzyme inhibition activity of five Salvia taxa from Turkey 2023
- Phytochemical analysis, antioxidant, and enzyme inhibition activity of five Salvia taxa from Turkey 2023
- Phytochemical analysis, antioxidant, and enzyme inhibition activity of five Salvia taxa from Turkey 2023
- Novel SARS-CoV-2 and COVID-2019 Outbreak: Current Perspectives on Plant-Based Antiviral Agents and Complementary Therapy 2020
- The antibiofilm effects of some Cistus spp. against pathogenic microorganisms 2022
- The antibiofilm effects of some Cistus spp. against pathogenic microorganisms 2022
- Anti HSV-1 Activity of Cistus laurifolius and Development of Antiviral Herbal Lip Balm 2024
- Anti HSV-1 Activity of Cistus laurifolius and Development of Antiviral Herbal Lip Balm 2024